Oestrogen receptor-related receptor alpha (ERRα) and oestrogen receptors (ERα and ERβ) exhibit different gene expression in human colorectal tumour progression

被引:91
作者
Cavallini, A
Notarnicola, M
Giannini, R
Montemurro, S
Lorusso, D
Visconti, A
Minervini, F
Caruso, MG
机构
[1] IRCCS, Natl Inst Digest Dis, Biochem Lab, I-70013 Bari, Italy
[2] Natl Inst Digest Dis, Div Digest Surg, Bari, Italy
[3] Inst Oncol, Unit Digest Surg, Bari, Italy
[4] ISPA, CNR, Bari, Italy
关键词
oestrogen receptor-related receptor; oestrogen receptor alpha; oestrogen receptor beta; colorectal carcinoma; tumour progression; peroxisome proliferator-activated receptor gamma coactivator-1; peroxisome proliferator-activated receptor gamma;
D O I
10.1016/j.ejca.2005.04.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have investigated the presence of oestrogen receptor-related (ERR) mRNA in human colorectal tumour tissues and adjacent normal mucosa by reverse transcriptase and nested-polymerase chain reaction. ERR alpha was found in 100% of the patients and ERR gamma in approximately 30% while ERR beta was not detected at all. The multiplex PCR analysis showed elevated levels of ERR alpha mRNA in tumour tissue compartment as compared to normal mucosa, whereas ERR gamma mRNA was found in lower levels but in both tissue compartments. In contrast, oestrogen receptor (ER alpha and ER beta) mRNA levels were shown to be decreased in tumour tissues. A positive correlation was observed between ER alpha and ER beta and between ER alpha and ERR alpha, respectively, in normal mucosa but not in tumour tissue. ERR alpha expression in tumour tissues significantly increased from TNM stages II to IV, whereas both ERs progressively declined. These findings suggest that ERR alpha, as well as the two ERs, might play a critical role in the progression of the colorectal cancer. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1487 / 1494
页数:8
相关论文
共 29 条
[1]  
Ariazi EA, 2002, CANCER RES, V62, P6510
[2]  
Bull AW, 2003, ARCH PATHOL LAB MED, V127, P1121
[3]  
Campbell-Thompson M, 2001, CANCER RES, V61, P632
[4]   Distribution of estrogen receptor subtypes, expression of their variant forms, and clinicopathological characteristics of human colorectal cancer [J].
Cavallini, A ;
Messa, C ;
Pricci, M ;
Caruso, ML ;
Barone, M ;
Di Leo, A .
DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (12) :2720-2728
[5]   Estrogen plus progestin and colorectal cancer in postmenopausal women [J].
Chlebowski, RT ;
Wactawski-Wende, J ;
Ritenbaugh, C ;
Hubbell, FA ;
Ascensao, J ;
Rodabough, RJ ;
Rosenberg, CA ;
Taylor, VM ;
Harris, R ;
Chen, C ;
Adams-Campbell, LL ;
White, E ;
Alving, B ;
Rossouw, J ;
Pottern, L ;
Ludlam, S ;
McGowan, J ;
Prentice, R ;
Anderson, G ;
LaCroix, A ;
Patterson, R ;
McTiernan, A ;
Cochrane, B ;
Hunt, J ;
Tinker, L ;
Kooperberg, C ;
McIntosh, M ;
Wang, CY ;
Chen, C ;
Bowen, D ;
Kristal, A ;
Stanford, J ;
Urban, N ;
Weiss, N ;
White, E ;
Shumaker, S ;
Rautaharju, P ;
Prineas, R ;
Naughton, M ;
Stein, E ;
Laskarzewski, P ;
Cummings, S ;
Nevitt, M ;
Dockrell, M ;
Harnack, L ;
Cammarata, F ;
Lindenfelser, S ;
Psaty, B ;
Heckbert, S ;
Wassertheil-Smoller, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :991-1004
[6]  
Di Leo A., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P1
[7]   PROGNOSTIC VALUE OF CYTOSOLIC ESTROGEN-RECEPTORS IN HUMAN COLORECTAL-CARCINOMA AND SURROUNDING MUCOSA - PRELIMINARY-RESULTS [J].
DILEO, A ;
MESSA, C ;
MISCIAGNA, G ;
GUERRA, V ;
TAVERI, R ;
LEO, S .
DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (09) :2038-2042
[8]   Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer:: reduced expression of PPARγ-coactivator 1 (PGC-1) [J].
Feilchenfeldt, J ;
Bründler, MA ;
Soravia, C ;
Tötsch, M ;
Meier, CA .
CANCER LETTERS, 2004, 203 (01) :25-33
[9]  
Foley EF, 2000, CANCER RES, V60, P245
[10]   IDENTIFICATION OF A NEW CLASS OF STEROID-HORMONE RECEPTORS [J].
GIGUERE, V ;
YANG, N ;
SEGUI, P ;
EVANS, RM .
NATURE, 1988, 331 (6151) :91-94